Courtney A. McNamara
<p>Courtney McNamara, MD, is Associate Program Director, Pediatric Residency Program at the Children’s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on pediatric hospital medicine, with a particular interest in resident education and mentorship.</p><p>In 2006, Dr. McNamara received her Bachelor of Science at James Madison University. She pursued her medical education at New York Medical College, earning her Doctor of Medicine in 2010. She then came to CHAM for her postgraduate training, completing her pediatric residency in 2013.</p><p>Dr. McNamara’s research focuses on improving the patient experience. She is a co-investigator in a grant funded project investigating communication with hospitalized patients with limited English proficiency, and her body of research includes quality improvement research studies focused on improving inpatient pediatric comfort and decreasing painful experiences. She has shared her work through peer-reviewed journals, abstracts, poster presentations and platform presentations.</p><p>Dr. McNamara is board certified in both General Pediatrics and Pediatric Hospital Medicine by the American Board of Pediatrics. She is a member of the American Academy of Pediatrics. In 2023, Dr. McNamara was inducted into the Leo M. Davidoff Society.</p>
Beth N. McLellan
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Beth McLellan graduated with honors from Northwestern University and attended medical school at Wayne State University where she graduated with Alpha Omega Alpha honors. She completed an internship in Internal Medicine at Loyola University Health System and her Dermatology residency at Henry Ford Health System in Detroit where she also served as Chief Resident. She currently is a Professor in the Department of Medicine (Dermatology) and has served as Chief of the Division of Dermatology since 2020.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan specializes in complex medical Dermatology and has a special interest in Supportive Oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair, and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis as well as successful use of bacterial decolonization for prevention of radiation dermatitis. She has published numerous articles and textbook chapters related to Supportive Oncodermatology and is regularly invited to speak at Dermatology and Oncology conferences for physicians and patients including the annual meeting of the American Academy of Dermatology, ASCO, and Gilda's Club.</span></p>
<p class="MsoNormal" style="margin-bottom: 0in; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Playing an active role in the Dermatology Residency, Dr. McLellan is the director of resident research and regularly lectures residents and medical students. She has served as a mentor to many residents and students and directs a year-long Oncodermatology research fellowship for medical students taking a year off for research. Interested medical students can learn more about the fellowship here: https://www.einsteinmed.edu/departments/medicine/divisions/dermatology/…;
<div> </div>
<div> </div>
<div> </div>
<p> </p>
Chemotherapy Side Effects
Scalp Cooling
Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.
Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis
<p>Beth N. McLellan, MD, is Chief, Dermatology, Director, Supportive Oncodermatology and Professor, Dermatology at Montefiore Einstein. She specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</p><p>After earning her Doctor of Medicine at Wayne State University, Dr. McLellan completed an internship in internal medicine at Loyola University Health System and her dermatology residency at Henry Ford Health System where she also served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institut Gustave Roussy in Paris, France.</p><p>Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis. Playing an active role in the Montefiore Einstein Dermatology Residency, Dr. McLellan is the Director of Resident Research and regularly lectures residents and medical students at both dermatology and oncology meetings. She has served as a mentor to many residents and students and directs a year long oncodermatology research fellowship for medical students taking a year off for research. Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology and is regularly invited to speak at dermatology and oncology conferences for physicians and patients, including the annual meeting of the American Academy of Dermatology, American Society of Clinical Oncology and Gilda's Club.</p><p>As part of her commitment to treating the whole patient, Dr. McLellan founded the New York Vitiligo Support Group. She has received awards from the Dermatology Foundation.</p>
Ranon E. Mann
As Program Director my clinical focus is patient care and resident education. My interests surround<br />complex medical dermatology.
Research focus on skin disorders affecting patients who are HIV positive.
Konstantinos Loupasakis
<p>Konstantinos Loupasakis, MD, is an attending rheumatologist at Montefiore Einstein and Rheumatology Fellowship Program Director and Associate Professor, Medicine at our Albert Einstein College of Medicine. Dr. Loupasakis sees patients with a wide range of rheumatologic diseases including rheumatoid arthritis, systemic lupus and multisystem sarcoidosis.</p><p>In 2007, Dr. Loupasakis earned his medical doctorate at University of Crete in Greece. He later came to the United States to further his medical training, completing his medical residency at Steward St. Elizabeth’s Medical Center, Tufts University School of Medicine in 2012, followed by his rheumatology fellowship at Hospital for Special Surgery, Weill Cornell Medical College of Cornell University in 2015 and a yearlong research fellowship at the same institution in 2016.</p><p>Dr. Loupasakis' research focus includes multisystem sarcoidosis, lupus, rheumatoid arthritis and medical education. He is a certified facilitator, teaching relationship-centered communication in healthcare, and is particularly interested in optimization of the patient-physician relationship. Dr. Loupasakis has shared his work through peer-reviewed journals, abstracts, poster presentations and invited national and regional presentations. He is also a reviewer for scientific rheumatology journals.</p><p>Dr. Loupasakis is board certified in Rheumatology by the American Board of Internal Medicine. He is a member of the American College of Rheumatology. Dr. Loupasakis has been twice recognized at Montefiore Einstein for his outstanding service and teaching, receiving an award in 2022 for his inpatient consult service and in 2024 for his outpatient service.</p>
Jonathan Jong-Jin Lee
<p> Jonathan H. Lee, MD is board certified orthopaedic and specializes in general orthopaedics and non-operative management of musculoskeletal conditions. </p><p> Dr. Lee obtained his medical degree from the Warren Alpert Medical School of Brown University. After completing his residency at New York Presbyterian Hospital, he completed fellowship in adult reconstruction and joint replacement at Hospital for Special Surgery. </p><p> Prior to joining Montefiore, Dr. Lee focused his research onthe causes and early stages of arthritis, causes at early stages as well as robotic and gps navigation techniquesfor joint replacement. At Einstein, he will continue his arthritis research including a collaboration with John Hardin, MD in rheumatology. </p>
Anand A. Kumthekar
<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;"><span class="s1" style="font-kerning: none;">Dr. Kumthekar is board certified in Internal Medicine and Rheumatology. He received his medical degree from Pravara Institute of Medical Sciences, India and trained in Internal Medicine at Jacobi Medical Center/Albert Einstein College of Medicine. He further completed his sub-specialty training in Rheumatology at Oregon Health and Science University.</span></p>
<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;"><span class="s1" style="font-kerning: none;">Dr. Kumthekar is an Assistant Professor of Medicine at Albert Einstein College of Medicine and an attending physician at Montefiore Medical Center. He is skilled in the treatment of general rheumatic illness and h</span>is clinical areas of focus include Ankylosing Spondylitis, Psoriatic arthritis, Rheumatoid arthritis, Vasculitis, Lupus and Myositis. He runs the Spondyloarthritis clinic at Montefiore and is profecient in musculoskeletal ultrasound. He has published multiple research articles and is a reviewer/editorial board member prominent medical journals.He has completed advanced MSK ultrasound training and is certified by the American College of Rheumatology (RhMSUS). He is a member of American College of Rheumatology, Spondyloarthritis Research and Treatment Network (SPARTAN), Group for Research and Assessment of. Psoriasis and Psoriatic Arthritis (GRAPPA) and Ultrasound School of North American Rheumatologists (USSONAR).</p>
<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;"> </p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* </strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Stienstra N, Horton J, Lane M, <strong>Kumthekar A,</strong> Sathe N, Sunny C, Yadav V, Deodhar A. Demyelinating Disease After Exposure to Tumor Necrosis Factor α Inhibitors: A Case Series in a Tertiary Care Center. JCR: Journal of Clinical Rheumatology. 2022 Mar 1;28(2):e638-41.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* </strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Patel S, <strong>Kumthekar A</strong>. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. Rheumatology and Therapy. 2021 Nov 19:1-23.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* </strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Bittar M, Dubreuil M. Educational needs and challenges in axial spondyloarthritis. Current Opinion in Rheumatology. 2021 Jul 1;33(4):313-8.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Kaur N, <strong>Kumthekar A</strong>, Ayesha B. When sarcoidosis mimics immunodeficiency. BMJ Case Reports CP. 2021 Jul 1;14(7):e243557.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Patel S, Bibi A, Eisenberg R, Gendlina I, Murakhovskaya I, Ramesh M, Balagula Y, <strong>Kumthekar A</strong>. The Role of Early Subspeciality Consultation in the Timing of Hemophagocytic Lymphohistiocytosis Diagnosis and Management. Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases. 2021 Jun 18.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* </strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Cui Z, Merritt Z, Assa A, Mustehsan H, Chung E, Liu S, <strong>Kumthekar A,</strong> Ayesha B, McCort M, Palaiodimos L, Baron S. Early and Significant Reduction in C-Reactive Protein Levels After Corticosteroid Therapy Is Associated With Reduced Mortality in Patients With COVID-19. Journal of Hospital Medicine. 2021 Feb 17.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Ayesha B,<strong> Kumthekar A</strong>, Jain R, Patel S, Ramesh M, Ferastraoaru DE, Hudes G, Karagic M, Zafar S, Bartash R, Vasquez‐Canizares N. Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatology. 2021 Feb 6.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* </strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Deodhar A. Axial Spondyloarthritis and Ankylosing Spondylitis. Physician Assistant Clinics.;6(1):135-47.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* Kumthekar A,</strong> Ogdie A. Obesity and Psoriatic Arthritis: A Narrative Review. Rheumatology and Therapy. 2020 Jun 3.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* Abbi B, Patel S, <strong>Kumthekar A</strong>, Schwartz D, Blanco I. A Case of Cardiomyopathy With Long-term Hydroxychloroquine Use. JCR: Journal of Clinical Rheumatology. 2020 May 9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Park SS, Akella S, <strong>Kumthekar A</strong>, Barmettler A. Extrapulmonary Sarcoidosis in the Orbit, Brain, and Heart. The American journal of medicine. 2019 Dec 17.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J. Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis. International journal of rheumatic diseases. 2019 Apr;22(4):592-8.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Raess PW, Ghetie D. A Missing Link: Sarcoid-Lymphoma Syndrome. The American Journal of Medicine. 2019 Jan 1;132(1):48-51.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Horton J, <strong>Kumthekar A.</strong> A Vanishing Entity: Rheumatoid Vasculitis. The American Journal of Medicine. 2018 Nov 1;131(11):1310-3.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Wolf B, Woltjer R, Schwab P. More than meets the eye: a case of HCV-induced PAN. Modern Rheumatology Case Reports. 2018 Jul 3;2(2):199-203.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Danve A, Deodhar A. Use of belimumab throughout 2 consecutive pregnancies in a patient with systemic lupus erythematosus. The Journal of Rheumatology. 2017 Sep 1;44(9):1416-7.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Deodhar A, <strong>Kumthekar A,</strong> Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Current opinion in rheumatology. 2017 Jul;29(4):293.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Akenroye AT, <strong>Kumthekar AA</strong>, Alevizos MK, Mowrey WB, Broder A. Implementing an electronic medical record–based reminder for cardiovascular risk screening in rheumatoid arthritis. Arthritis Care & Research. 2017 May;69(5):625-32.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Palkar P, <strong>Kumthekar A</strong>. Comment on: Dance-like movements in obsessive compulsive disorder. Indian journal of psychological medicine. 2017 May 1;39(3).</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Johnson B. Polyarticular severe tophaceous gout secondary to limited medication access. The Journal of rheumatology. 2015 Aug 1;42(8):1528-9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Palkar PY, <strong>Kumthekar AA.</strong> Roar of meow-meow (mephedrone) in India. Journal of Mental Health and Human Behaviour. 2015 Jul 1;20(2):55.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Cossarini F, Shih JC, Taub CC, Massera D. Ranolazine-induced repolarization changes: a case report. The American Journal of Medicine. 2015 Jul 1;128(7):e3-5.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar AA</strong>, Gidwani HV, Kumthekar AB. Metformin associated B12 deficiency. J Assoc Physicians India. 2012 Mar 1;60(3):58-9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Hitesh Vinod C, Misra BN, <strong>Kumthekar AA</strong>, Kawatra A. CALIBRATION AND CUFFING ISSUES CONCERNING SPHYGMOMANOMETER’S IN A TERTIARY HEALTH CARE CENTRE. Indian J. Prev. Soc. Med. 2013 Jul;44(3-4):166.</span></p>
Tobi B. Klar
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy.</span>
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema.</span>
<p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Tobi Klar, MD, is an attending physician and Assistant Professor at Montefiore-Einstein. Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy. Dr. Klar also treats cancers of the skin including melanoma, basal cell carcinoma and squamous cell carcinoma.<span> </span>She has advanced training and extensive experience treating adults and children for general dermatological conditions, including rashes, acne, rosacea and eczema. She also performs skin cancer screenings and treats premalignant and malignant conditions.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">After earning her Doctor of Medicine at the State University of New York Downstate in 1981, Dr. Klar continued at the institution for her postdoctoral training, completing her Internal Medicine Internship in 1982, her Internal Medicine Residency in 1983 and her Dermatology Residency in 1986.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema. </span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar is board certified and is a member of several professional associations including the Society for Clinical Vascular Surgery, the Society of Vascular Ultrasound and the Peripheral Vascular Surgery Society.</span></p>
Harold D. Keiser
<p>In years of clinical practice Dr. Harold Keiser has acquired experience over the broad range of problems referred to rheumatologists. Dr. Keiser takes special interest in the diagnosis and management of connective tissue disorders, gout, and the spondyloarthropathies.</p>
David M. Kaufman
<p><span style="font-family: Arial;">David Myland Kaufman, Professor of Neurology and Psychiatry and Behavioral Sciences, was graduated from the medical school of the University of Chicago and completed training in internal medicine and then neurology at Montefiore Medical Center / Albert Einstein College of Medicine (AECOM) hospitals. During his residency, Dr. Kaufman originated the nation-wide course, which he still directs, Clinical Neurology for Psychiatrists. More than 25,500 psychiatry residents and attendings have attended the course, which has served as the basis for his classic textbook, <em>Clinical Neurology for Psychiatrists</em>, (Elsevier) currently in its eighth edition and available in Italian, Japanese, and Spanish translations. He is also a co-editor of <em>Child and Adolescent Neurology for Psychiatrists</em> (Lippincott).</span></p>
<p><span style="font-family: Arial;">Dr. Kaufman has also been a visiting professor at Ben Gurion University, Yale University, Pritzger / University of Chicago, and other American medical schools, and U.S. Naval Medical Centers, as well as a frequent lecturer at AECOM. He is a member of medical school's Leo M. Davidoff Society for excellence in teaching. </span></p>
<p><span style="font-family: Arial;">In addition to his educational role at AECOM hospitals, Dr. Kaufman in partnership with Dr. Michael Swerdlow founded the quintessential neurology faculty practice K&S at Montefiore Hospital. K&S is the largest and longest surviving faculty practice in the institution. Drs. Kaufman and Swerdlow also give neurology consultation and attending rounds and supervise neurology clinics at Montefiore. In the clinics and faculty practice, Dr. Kaufman concentrates on the neurologic aspects of psychiatric illness and movement disorders. He works closely with the psychiatrists and, for botulinum treatment of certain dystonias, the neuromuscular group. Dr. Kaufman is the 2007 recipient of Montefiore's Staff and Alumni award for outstanding service.</span></p>
In addition to his educational role at AECOM and its hospitals, Dr. Kaufman in partnership with Dr. Michael Swerdlow founded the quintessential neurology faculty practice K&S at Montefiore Hospital. K&S is the largest and longest-surviving faculty practice in the institution. Drs. Kaufman and Swerdlow also give neurology consultations and attend rounds and supervise neurology clinics at Montefiore. In the clinics and faculty practice, Dr. Kaufman concentrates on the neurologic aspects of psychiatric illness and movement disorders. He works closely with psychiatrists and, for botulinum treatment of certain dystonia, the neuromuscular group.
From his research interests, Dr. Kaufman has published clinical studies of central nervous system infections, heroin overdose-induced pulmonary edema, Covid’s effect on Parkinson's disease patients, and other topics. He concentrates on teaching medical students in their neuroscience courses, psychiatry and neurology residents, and psychiatrists preparing for their Board examinations.
<p>Kaufman DM, Geyer HL, Milstein MM: "Kaufman's Clinical Neurology for Psychiatrists," Elsevier, 8th Edition, 2017</p>
<p>Kaufman DM, Smuckler DJ: Neurologic Disease (in) Blumenfeld M, Strain JJ, "Psychosomatics," Lippincott Williams & Wilkins, 2006</p>
<p>David Kaufman, MD, an attending physician and Professor of Neurology and of Psychiatry and Behavioral Sciences at Montefiore Einstein, concentrates on the neurologic aspects of psychiatric illness and movement disorders. He provides neurology consultations for in-patients and out-patients, serves as the attending on consultation and ward rounds, and supervises neurology clinics at Montefiore Einstein. He works closely with psychiatrists and, for botulinum treatment of certain dystopias, the neuromuscular group.</p><p>After earning his Bachelor of Arts from the University of Rochester in 1964, Dr. Kaufman earned his Doctor of Medicine degree from the University of Chicago School of Medicine in 1968. He pursued his postdoctoral training at Montefiore, completing his internal medicine internship and residency in 1971. In 1975, he completed the four-year neurology residency at Albert Einstein College of Medicine hospitals. He has been a steadfast member of Montefiore and Einstein communities ever since.</p><p>From his research interests, Dr. Kaufman has published clinical studies of central nervous system infections, heroin overdose-induced pulmonary edema, COVID’s effect on Parkinson disease patients, and other topics. He has been a member of editorial boards for Internal Medicine Bulletin and Medical Meetings: Pearls & Perspectives, and a consultant and reviewer for numerous medical journals. He teaches medical students in their neuroscience course, psychiatry and neurology residents, and psychiatrists preparing for their Board examinations. He has been a Visiting Professor at Ben Gurion University, Yale University, Pritzker/University of Chicago, and other American medical schools, and at U.S. Naval Medical Centers, as well as a frequent lecturer at the Albert Einstein College of Medicine.</p><p>Dr. Kaufman innovated the long-standing, annual, national course, Clinical Neurology and Psychiatry for Psychiatrists, developed a noteworthy neuropsychiatry seminar and authored the book, <em>Kaufman’s Clinical Neurology for Psychiatrists</em>, now in its 9th edition.</p><p>Dr. Kaufman is board certified in Internal Medicine, and Psychiatry and Neurology. He is a fellow of the American Academy of Neurology and the American College of Physicians. He is also a member of the American Neuropsychiatric Association and the Movement Disorder Society. A devoted educator, Dr. Kaufman has received many accolades for his excellence in medical teaching, including induction into the Leo M. Davidoff Society in 1993, the American Academy of Neurology award in 2001 and the Montefiore Staff and Alumni Award in 2007.</p>